← Eichor
Study identifier: NCT06718920 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment

Condition: Multiple Sclerosis  ·  Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are: * Does the presence of ACE impact on quality of life of patients with multiple sclerosis? * Does it influence how the patients cope with the disease and with disease course-modifying therapies? During follow up visits, planned as part of their regular medical care, participants will answer survey questions on a tablet .

This description comes directly from the study's public registry record.

Talk to the study team

Massimiliano Mirabella, Neurology Associate Professor  ·  0630155390  ·  massimiliano.mirabella@policlinicogemelli.it

Alessandra Cicia, Neurologist  ·  0630155390  ·  cicia.alessandra@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCSRome, RM, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06718920